Loading...

Loading...

Boehringer Ingelheim Expands Diabetes Care in Mexico
By Sofía Garduño - Fri, 11/28/2025 - 09:35
Boehringer Ingelheim expands its partnership with Clínicas del Azúcar to open four new diabetes care centers in Mexico.
https://mexicobusiness.news/tag/boehringer-ingelheim
More Health
OMNI Buys Marzam, Boehringer Expands in Mexico
By Sofía Garduño - Thu, 08/14/2025 - 10:42
This week, Grupo OMNI buys Marzam, Boehringer expands its Xochimilco plant, and Novartis reports positive Phase III results for Sjögren’s drug.
Boehringer Ingelheim Invests US$188 Million in Xochimilco Plant
By MBN Staff - Tue, 08/12/2025 - 09:32
Boehringer Ingelheim invests MX$3.5 billion (US$188 million) to expand its Xochimilco plant, boosting production and exports globally.
Pharma Firms Invest US$643M to Expand in Mexico
By Aura Moreno - Thu, 08/07/2025 - 12:38
Mexico attracts US$643 million in pharma investment to boost research, production, and exports under Sheinbaum’s strategy for health sovereignty.
Pharma Sector to Invest MX$12 Billion / First Development Pole
By Fernando Mares - Thu, 08/07/2025 - 12:24
Four pharmaceutical companies will invest MX$12 billion to expand their production and research capacity, aligning with Plan México.
Boehringer Ingelheim, Veeva Launch One Medicine Platform
By MBN Staff - Thu, 03/13/2025 - 17:42
Boehringer Ingelheim and Veeva Systems launch the One Medicine platform, streamlining drug development through Veeva Development Cloud.
Sleep Trends, Mental Health Funding: The Week in Health
By Sofía Garduño - Thu, 10/24/2024 - 10:00
This week, TikTok’s "sleepmaxxing" trend aims to improve sleep but faces doubts. Boehringer Ingelheim and WHO aim to improve mental health.
Boehringer Ingelheim, WHO Pledge US$5M to Improve Mental Health
By MBN Staff - Fri, 10/18/2024 - 14:20
Boehringer Ingelheim and the WHO Foundation each pledge US$5M to improve access to mental health services in the Americas.
Boehringer Ingelheim's Survodutide Receives FDA Approval
By MBN Staff - Tue, 10/15/2024 - 10:07
Boehringer Ingelheim's survodutide gains FDA Breakthrough Therapy designation for MASH, advancing treatment options.

Potential New Treatment for Heart Failure
By Miriam Bello - Fri, 07/09/2021 - 15:03
New treatment might reduce death and hospitalizations from heart failure, which affects over 60 million people.